CORRESPONDENCE
Contact Order Wolverine
Editorial questions, corrections, and sourcing notes about the BPC-157 TB-500 digest are welcome. This is an editorial desk, not a clinic and not a sales channel.
Editorial inquiries only
Use the form to reach the desk about the BPC-157 TB-500 record. Every message about a citation, a figure, a possible error, or a regulatory update worth reflecting gets read. If a study has been superseded, a DOI has moved, or the FDA record has changed, point it out and it will be checked against the primary source.
What this desk is not, said plainly: it is no clinic, no pharmacy, no prescriber, no vendor. It cannot assess your health, recommend a dose, supply any peptide, or advise on obtaining the Wolverine blend, and it offers neither medical nor legal advice. Questions of that kind belong with an appropriately licensed professional, not with a set of pages that keep a formulary.
What to expect
We prioritize messages that improve the accuracy of the record: a miscited PMID, a number that does not match the source paper, a regulatory development we have not yet incorporated, or a place where the Wolverine legal status and FDA 503A compounding access page should be updated to reflect a new FDA action. Corrections grounded in a primary source are the fastest to act on.
We do not collect personal health information, and we ask that you not send any. Keep inquiries to the editorial content itself — the studies, the citations, the regulatory status, and the way the blend's evidence is set down on these pages. For the underlying sources, the full reference list with PMIDs and DOIs lists everything cited, with DOIs and PubMed or FDA links, so a correction can be checked against the primary record before we change anything in the register.